Community Pharmacy England (CPE) - News updates

The Department of Health and Social Care (DHSC) has today (16/01/2026) confirmed the following initial list of price concessions for January 2026: Drug Pack size Price concession Amoxicillin 250mg/5ml oral suspension 100 £1.44 Aspirin 75mg dispersible tablets 28 £2.19 Aspirin 75mg dispersible tablets 100 £7.82 Betamethasone 500microgram soluble tablets sugar free 100 £47.89 Carbocisteine 375mg [...] The post January 2026 Price Concessions 1st Update appeared first on Community Pharmacy England.

Update 16/01/26 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Creon® 25000 gastro-resistant capsules (SSP061) was due to expire 16 January 2026 but has been further extended to Friday 17 April 2026. Update 20/11/25 – The Department of Health and Social Care (DHSC) [...] The post SSP61 – Creon® 25000 gastro-resistant capsules further extended appeared first on Community Pharmacy England.

Update 16/01/26 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Creon® 25000 gastro-resistant capsules (SSP061) was due to expire 16 January 2026 but has been further extended to Friday 30 January 2026. Update 20/11/25 – The Department of Health and Social Care (DHSC) [...] The post SSP60 – Creon® 10000 gastro-resistant capsules further extended appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets. MSN/2026/002 Tier 2 – Medium impact Date of issue: 15 January 2026 Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets were discontinued on 5th January 2026. Various strengths (0.7mg/0.18mg, 1.4mg/0.36mg, 5.7mg/1.4mg, 8.6mg/2.1mg, and 11.4mg/2.9mg) of [...] The post Medicine Supply Notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets appeared first on Community Pharmacy England.

The NHS Business Services Authority (NHSBSA) has published the questions which will be included in the 2025/26 Pharmacy Quality Scheme (PQS) declaration so pharmacy owners can view these ahead of making their declaration when the declaration window opens. The questions are available on the NHSBSA PQS hub page; scroll down to the ‘PQS 2025/26’ section where [...] The post PQS declaration questions published appeared first on Community Pharmacy England.

Alongside critical work making the financial case for the sector, Community Pharmacy England will be working with Pharmacist Support in 2026 to help support the wellbeing of pharmacists and their teams. The continuing fragility of pharmacy finances, alongside high workloads, stress, ongoing uncertainty and rising reports of patient abuse across England, take a real toll [...] The post Supporting you in 2026: Our work with Pharmacist Support appeared first on Community Pharmacy England.

Update 15/01/2026: DHSC has issued a Medicine supply Notification for Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets. Pharmacy teams should be aware that all strengths of Subutex® and Suboxone® tablets have been discontinued. The manufacturer, Indivior, is no longer supplying these products in the UK therefore, they are no longer available for community pharmacies [...] The post Discontinuation of Subutex® and Suboxone® tablets appeared first on Community Pharmacy England.

This article tackles some of the misconceptions around rejecting Pharmacy First referrals and aims to bust myths to increase understanding of the service. We have previously published a series of articles on myth busting covering a variety of aspects of Pharmacy First. All of these myths can be viewed on our Pharmacy First service – [...] The post Pharmacy First myth busting: To reject or not to reject? appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Co-codamol 30mg/500mg tablets. MSN/2026/001 Tier 3 – High impact Date of issue: 12 January 2026 Co-codamol 30mg/500mg tablets will be in limited supply from early February until early June 2026. Paracetamol 500mg tablets remain available and can support a full uplift [...] The post Medicine Supply Notification: Co-codamol 30mg/500mg tablets appeared first on Community Pharmacy England.

Community Pharmacy England will be holding a webinar in collaboration with NHS England about the new Seasonal Vaccination Service on Wednesday 21st January at 7.30pm. The new Advanced service covers the provision of both seasonal vaccinations (COVID-19 and adult flu) in community pharmacy for the 2026/27 season. On the night David Onuoha, Service Development Manager and [...] The post Seasonal Vaccination Service 2026/27 – webinar appeared first on Community Pharmacy England.